Palonosetron 0.25 Mg Injection 0.25 mg/5 mL vial Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 0.25 mg/5 mL vial
Reference Brands: Posfrea (USA)
Category: Oncology Cancer Care
Palonosetron Injection 0.25 mg/5 mL is a 5-HT3 receptor antagonist used to prevent chemotherapy-induced nausea and vomiting (CINV). Approved in both the U.S. and EU, it is particularly effective for patients undergoing highly emetogenic chemotherapy. Available in a single-dose vial for IV administration, it plays a key role in oncology B2B distribution, helping oncology centers manage chemotherapy side effects and improve patient comfort.
Product Description:
Palonosetron Injection 0.25 mg/5 mL is a 5-HT3 receptor antagonist used to prevent chemotherapy-induced nausea and vomiting (CINV). It is particularly effective for patients undergoing highly emetogenic chemotherapy regimens. Approved in both the U.S. (under the brand name Aloxi) and the EU, Palonosetron is available as a single-dose 0.25 mg/5 mL vial for IV administration. This drug is essential in oncology B2B distribution, helping oncology centers and hospitals manage the side effects of chemotherapy, ensuring better patient outcomes by reducing nausea and vomiting after treatment.
Palonosetron 0.25 Mg Injection — third party manufacturing & bulk supply
Palonosetron 0.25 Mg Injection 0.25 mg/5 mL vial is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Palonosetron 0.25 Mg Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Palonosetron 0.25 Mg Injection →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Palonosetron is used to prevent nausea and vomiting associated with cancer chemotherapy and surgical procedures. It is particularly effective in preventing delayed nausea and vomiting that may occur several hours to days after treatment.
Palonosetron is a chemically synthesized compound that belongs to the class of serotonin (5-HT₃) receptor antagonists. It works by blocking serotonin receptors involved in triggering nausea and vomiting.
Palonosetron is marketed under the trade name Aloxi.
The original brand Aloxi was developed and marketed by Helsinn Healthcare. Today, palonosetron is also manufactured by multiple pharmaceutical companies worldwide as branded and generic versions.
The generic name is palonosetron (commonly used as palonosetron hydrochloride).
The most well-known brand name is Posfrea, Aloxi, along with various country-specific branded generics.
Palonosetron is manufactured in several countries including the USA, EU nations, India, and other regulated markets by approved pharmaceutical manufacturers following international quality and regulatory standards.
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
